Corcept Therapeutics (CORT) has a market capitalization of $9.3B, based on 108.1M shares at a price of $86.32 (down 1% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2026 | $87.59 | 16,815,319 | 108,098,392 | $9,468,338,155.28 |
September 2026 | $115.23 | 36,121,700 | 118,385,000 | $13,641,503,550.00 |
August 2026 | $113.35 | 18,238,454 | 118,385,000 | $13,418,939,750.00 |
July 2026 | $114.49 | 29,708,600 | 118,385,000 | $13,553,898,650.00 |
June 2026 | $86.95 | 21,161,400 | 118,385,000 | $10,293,575,750.00 |
May 2026 | $69.49 | 25,898,100 | 118,385,000 | $8,226,573,650.00 |
April 2026 | $46.52 | 22,248,000 | 118,385,000 | $5,507,270,200.00 |
March 2026 | $40.31 | 42,302,400 | 104,435,000 | $4,209,774,850.00 |
February 2026 | $35.70 | 37,693,778 | 104,435,000 | $3,728,329,500.00 |
January 2026 | $39.87 | 53,713,496 | 104,435,000 | $4,163,823,450.00 |
December 2025 | $34.80 | 43,530,385 | 119,855,000 | $4,170,954,000.00 |
November 2025 | $79.40 | 12,168,965 | 119,855,000 | $9,516,487,000.00 |
October 2025 | $73.47 | 21,056,971 | 119,855,000 | $8,805,746,850.00 |
September 2025 | $83.11 | 18,822,410 | 119,439,000 | $9,926,575,290.00 |
August 2025 | $69.72 | 16,214,709 | 119,439,000 | $8,327,287,080.00 |
July 2025 | $67.17 | 19,932,690 | 119,439,000 | $8,022,717,630.00 |
June 2025 | $73.40 | 37,901,299 | 120,485,000 | $8,843,599,000.00 |
May 2025 | $77.56 | 25,289,747 | 120,485,000 | $9,344,816,600.00 |
April 2025 | $71.88 | 40,790,019 | 120,485,000 | $8,660,461,800.00 |
March 2025 | $114.22 | 36,121,083 | 119,819,000 | $13,685,726,180.00 |
February 2025 | $60.58 | 19,814,689 | 119,819,000 | $7,258,635,020.00 |
January 2025 | $66.92 | 17,770,550 | 119,819,000 | $8,018,287,480.00 |
December 2024 | $50.39 | 17,647,980 | 118,459,000 | $5,969,149,010.00 |
November 2024 | $57.68 | 19,758,397 | 118,459,000 | $6,832,715,120.00 |
October 2024 | $48.97 | 24,929,176 | 118,459,000 | $5,800,937,230.00 |